ES2536206T3 - Parche medicinal - Google Patents

Parche medicinal Download PDF

Info

Publication number
ES2536206T3
ES2536206T3 ES09715573.3T ES09715573T ES2536206T3 ES 2536206 T3 ES2536206 T3 ES 2536206T3 ES 09715573 T ES09715573 T ES 09715573T ES 2536206 T3 ES2536206 T3 ES 2536206T3
Authority
ES
Spain
Prior art keywords
agent
free base
pharmaceutical agent
varenicline
solubilizer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09715573.3T
Other languages
English (en)
Inventor
Naoki Yamamoto
Kumi Morimoto
Akio Takeuchi
Kenji Ishigaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41015879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2536206(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Application granted granted Critical
Publication of ES2536206T3 publication Critical patent/ES2536206T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Parche medicinal que comprende como agente farmaceutico vareniclina en su forma de base libre, un material de base adhesivo, un agente de pegajosidad, un solubilizante y una sal de metal, en el que vareniclina en su forma de base libre y la sal de metal pueden obtenerse mediante reaccion de neutralizacion entre la sal de adicion de acido del agente farmaceutico e hidroxido de metal, que se anade en una cantidad para convertir la totalidad o una parte del agente farmaceutico en la base libre, el material de base adhesivo es un material de base adhesivo de caucho y el agente de pegajosidad es un agente de pegajosidad no basado en colofonia seleccionado del grupo que consiste en resinas de hidrocarburo alifatico y resinas de hidrocarburo aliciclico, y el solubilizante se selecciona del grupo que consiste en propilenglicol y dipropilenglicol.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8

Claims (1)

  1. imagen1
ES09715573.3T 2008-02-27 2009-02-09 Parche medicinal Active ES2536206T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008046804 2008-02-27
JP2008046804 2008-02-27
PCT/JP2009/052177 WO2009107477A1 (ja) 2008-02-27 2009-02-09 貼付製剤

Publications (1)

Publication Number Publication Date
ES2536206T3 true ES2536206T3 (es) 2015-05-21

Family

ID=41015879

Family Applications (3)

Application Number Title Priority Date Filing Date
ES09715476T Active ES2778724T3 (es) 2008-02-27 2009-02-09 Parche
ES09715573.3T Active ES2536206T3 (es) 2008-02-27 2009-02-09 Parche medicinal
ES09715635.0T Active ES2648197T3 (es) 2008-02-27 2009-02-09 Parche medicado

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES09715476T Active ES2778724T3 (es) 2008-02-27 2009-02-09 Parche

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES09715635.0T Active ES2648197T3 (es) 2008-02-27 2009-02-09 Parche medicado

Country Status (5)

Country Link
US (3) US20110028880A1 (es)
EP (3) EP2258369B1 (es)
JP (3) JP6054013B2 (es)
ES (3) ES2778724T3 (es)
WO (3) WO2009107479A1 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2513691T3 (es) 2009-05-21 2014-10-27 Hisamitsu Pharmaceutical Co., Inc. Preparación transdérmica
JP2011074035A (ja) * 2009-09-30 2011-04-14 Sekisui Medical Co Ltd 貼付剤
JP5615898B2 (ja) * 2010-02-24 2014-10-29 久光製薬株式会社 貼付剤
JP5665330B2 (ja) * 2010-02-24 2015-02-04 久光製薬株式会社 ニコランジル分解抑制剤、経皮吸収製剤及び貼付剤
JP5615899B2 (ja) 2010-02-24 2014-10-29 久光製薬株式会社 経皮吸収製剤
JP5623102B2 (ja) * 2010-03-12 2014-11-12 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
WO2011118683A1 (ja) * 2010-03-25 2011-09-29 東洋化学株式会社 医用貼付剤
MX2012012069A (es) 2010-04-30 2012-11-22 Teikoku Pharma Usa Inc Composiciones transdermicas de propinilaminoindan.
WO2011140431A1 (en) * 2010-05-06 2011-11-10 Teva Pharmaceutical Industries Ltd. Varenicline salts and crystal forms thereof
KR101853082B1 (ko) * 2011-03-24 2018-04-27 테이코쿠 팔마 유에스에이, 인코포레이티드 활성제층 및 활성제 변환층을 포함하는 경피 조성물
KR101848961B1 (ko) * 2011-05-31 2018-04-13 히사미쓰 세이야꾸 가부시키가이샤 로피니롤 함유 첩부제 및 그 포장체
WO2012165253A1 (ja) * 2011-05-31 2012-12-06 久光製薬株式会社 ロピニロール含有貼付剤及びその包装体
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same
KR102013477B1 (ko) * 2012-07-26 2019-08-22 히사미쓰 세이야꾸 가부시키가이샤 첩부제
US11123305B2 (en) 2012-07-26 2021-09-21 Hisamitsu Pharmaceutical Co., Inc. Patch
JP6050896B2 (ja) 2012-11-02 2016-12-21 テイコク ファーマ ユーエスエー インコーポレーテッド プロピニルアミノインダン経皮組成物
CN105246490A (zh) 2013-03-15 2016-01-13 伊利克斯根公司 使用zscan4复壮人细胞的方法
JP5415645B1 (ja) 2013-06-28 2014-02-12 久光製薬株式会社 貼付剤の製造方法、貼付剤及び包装体
JP6324964B2 (ja) * 2013-08-23 2018-05-16 久光製薬株式会社 貼付剤
WO2015037639A1 (ja) * 2013-09-11 2015-03-19 株式会社 メドレックス テープ剤の新規な基剤組成物
JP6100150B2 (ja) * 2013-12-06 2017-03-22 久光製薬株式会社 ４−アミノピリジン含有貼付剤
JP2016079102A (ja) * 2014-10-10 2016-05-16 テバ製薬株式会社 ソリフェナシン含有製剤
CN104636140B (zh) * 2015-01-29 2018-05-29 小米科技有限责任公司 固件压缩方法、固件解压方法和装置
KR102005201B1 (ko) * 2015-07-27 2019-07-29 히사미쓰 세이야꾸 가부시키가이샤 아세나핀 함유 첩부제의 제조 방법
US9974858B2 (en) 2015-08-29 2018-05-22 Medrx Co., Ltd Percutaneous absorption composition
WO2017037813A1 (ja) * 2015-08-29 2017-03-09 株式会社メドレックス 塩基性薬物とソルビン酸とを含有する経皮吸収組成物
US10016502B2 (en) 2015-08-29 2018-07-10 Medrx Co., Ltd Patch preparation containing an acid scavenger
WO2017037812A1 (ja) 2015-08-29 2017-03-09 株式会社メドレックス 酸捕捉剤を含有する貼付製剤
KR102771688B1 (ko) * 2016-09-07 2025-02-20 에스케이케미칼 주식회사 바레니클린의 경피 투여를 위한 약학 제제
ES2769286T3 (es) 2016-12-20 2020-06-25 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico que contiene asenapina
WO2018115010A1 (en) 2016-12-20 2018-06-28 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
EP3586841B1 (en) 2017-02-24 2023-12-27 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product thereof
ES2881783T3 (es) 2017-06-26 2021-11-30 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico que contiene asenapina y polímero de acrílico y silicona
DE102017115701B4 (de) * 2017-07-12 2022-03-03 Lts Lohmann Therapie-Systeme Ag Fampridin-TTS
CA3101420A1 (en) 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
CN112533593A (zh) 2018-06-20 2021-03-19 罗曼治疗系统股份公司 含有阿塞那平的透皮治疗系统
US10919288B2 (en) * 2018-07-20 2021-02-16 Procraft Development Bv Method of producing a multilayered product
JP7201389B2 (ja) * 2018-07-20 2023-01-10 プロクラフト、ディベロップメント、ベスローテン、フェンノートシャップ 多層生成物を製造する方法
JP6908800B1 (ja) 2019-09-18 2021-07-28 久光製薬株式会社 ロピニロール含有貼付剤及びロピニロールの皮膚透過性向上方法
JP7284877B2 (ja) 2020-10-29 2023-05-31 久光製薬株式会社 ロピニロール含有貼付剤及びロピニロールの皮膚透過性向上方法
JP7385614B2 (ja) * 2021-03-10 2023-11-22 積水化学工業株式会社 貼付製剤
EP4380548A4 (en) * 2021-08-07 2025-07-09 Lupin Ltd STABILIZED SOLID ORAL PHARMACEUTICAL COMPOSITION OF VARENICLINE
CN116370439A (zh) * 2022-04-01 2023-07-04 江苏山信药业有限公司 一种伐尼克兰透皮贴剂及其制备方法和其应用

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059189A (en) * 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
JP2733936B2 (ja) 1987-11-19 1998-03-30 トヨタ自動車株式会社 生産指示装置
JPH01147233A (ja) 1987-12-03 1989-06-08 Daisen:Kk 簡易住宅における室内の温度調節方法
JPH01160475A (ja) 1987-12-17 1989-06-23 Hitachi Plant Eng & Constr Co Ltd 微生物固定化装置
DE69009540T2 (de) * 1989-03-15 1994-09-29 Nitto Denko Corp Arzneimittel enthaltendes Heftpflaster.
AU644815B2 (en) 1989-09-08 1993-12-23 Ortho-Mcneil Pharmaceutical, Inc. Solid matrix system for transdermal drug delivery
DE4210711A1 (de) 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
US5676968A (en) 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
GB9511366D0 (en) 1995-06-06 1995-08-02 Smithkline Beecham Plc Novel formulations
US5807570A (en) 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
DE19546024C2 (de) * 1995-12-09 1998-09-10 Lohmann Therapie Syst Lts Transdermale pharmazeutische Zubereitung und deren Herstellung
JPH09299444A (ja) * 1996-05-14 1997-11-25 Sekisui Chem Co Ltd ニトログリセリン貼付剤用包装体
US7150881B2 (en) * 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
JP4703795B2 (ja) 1997-07-15 2011-06-15 帝國製薬株式会社 皮膚疾患治療用シート製剤
JPH1147233A (ja) 1997-07-30 1999-02-23 Teikoku Seiyaku Co Ltd 貼付剤および貼付剤の保存方法
JPH11209271A (ja) 1998-01-23 1999-08-03 Nitto Denko Corp 経皮吸収製剤
US6146656A (en) * 1998-01-22 2000-11-14 Nitto Denko Corporation Percutaneous absorption preparation
JPH11209270A (ja) 1998-01-22 1999-08-03 Nitto Denko Corp 経皮吸収製剤
DE19811218A1 (de) 1998-03-14 1999-09-16 Lohmann Therapie Syst Lts Silikonhaftkleber mit vermindertem Kalten Fluß
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE19814087A1 (de) 1998-03-30 1999-10-14 Lohmann Therapie Syst Lts Feuchtigkeitsaktivierbares therapeutisches System
DE19814083C2 (de) * 1998-03-30 2002-02-07 Lohmann Therapie Syst Lts Verfahren zur Herstellung von transdermalen therapeutischen Systemen unter Verwendung von basischen Alkalimetallsalzen zur Umwandlung von Wirkstoffsalzen in die freien Basen
DE19828273B4 (de) 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US20050074487A1 (en) 1999-12-16 2005-04-07 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US20020192243A1 (en) * 1999-12-16 2002-12-19 Tsung-Min Hsu Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers
WO2001043734A2 (en) 1999-12-16 2001-06-21 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
WO2001052823A2 (en) * 2000-01-20 2001-07-26 Noven Pharmaceuticals, Inc. Compositions to effect the release profile in the transdermal administration of drugs
EP1340496A4 (en) 2000-11-07 2004-04-14 Hisamitsu Pharmaceutical Co PHARMACEUTICAL PREPARATION OF THE PERCUTANEOUS ABSORPTION TYPE
US20020106402A1 (en) 2000-12-05 2002-08-08 Hartwig Rod Lawson Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use
BR0207955A (pt) 2001-03-07 2004-02-25 Hisamitsu Pharmaceutical Co Agente de emplastro
US6830758B2 (en) 2001-04-02 2004-12-14 Lectec Corporation Psoriasis patch
US20020192273A1 (en) 2001-06-15 2002-12-19 Teri Buseman Therapeutic patch useful for the treatment of hemorrhoids
US7921999B1 (en) 2001-12-20 2011-04-12 Watson Laboratories, Inc. Peelable pouch for transdermal patch and method for packaging
US20030180347A1 (en) * 2002-03-19 2003-09-25 W.F. Young, Incorporated Patch for the delivery of topical agents
DE10220230A1 (de) 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
EP1386604A1 (en) * 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system
JP4792193B2 (ja) 2002-08-28 2011-10-12 久光製薬株式会社 貼付剤
WO2004062600A2 (en) 2003-01-08 2004-07-29 Lectec Corporation Antiviral patch
JP2005168898A (ja) 2003-12-12 2005-06-30 Aruze Corp 遊技機、遊技サーバおよび遊技システム
WO2005117886A1 (ja) 2004-06-01 2005-12-15 Hisamitsu Pharmaceutical Co., Inc. 貼付剤
US8252321B2 (en) * 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
MX2007004495A (es) * 2004-10-15 2007-05-10 Pfizer Prod Inc Composiciones y procedimientos para la administracion intranasal, bucal, sublingual y pulmonar de vareniclina.
WO2006082728A1 (ja) 2005-02-04 2006-08-10 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収貼付剤
US20090220580A1 (en) 2005-04-20 2009-09-03 Senju Pharmaceutical Co., Ltd. Percutaneous Absorption Formulation
JP5025998B2 (ja) 2005-06-06 2012-09-12 日東電工株式会社 経皮吸収製剤
EP1731143B1 (en) * 2005-06-06 2008-11-26 Nitto Denko Corporation Percutaneous absorption-type pharmaceutical preparation using a metal chloride, preferably sodium chloride, for preventing cohesive failure
JP4999366B2 (ja) * 2005-06-06 2012-08-15 日東電工株式会社 経皮吸収製剤
US20110086086A1 (en) 2005-07-26 2011-04-14 Pfizer Inc Transdermal system for varenicline
US9056061B2 (en) * 2005-09-23 2015-06-16 Alza Corporation Transdermal nicotine salt delivery system
US8158152B2 (en) 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
JP4769575B2 (ja) 2005-12-28 2011-09-07 帝國製薬株式会社 貼付剤及びその製造方法
JP5684441B2 (ja) * 2005-12-28 2015-03-11 久光製薬株式会社 インドメタシン含有貼付剤
JP5037831B2 (ja) * 2006-02-15 2012-10-03 久光製薬株式会社 凝集力向上及び徐放化の外用貼付剤
JP5010834B2 (ja) 2006-02-20 2012-08-29 帝國製薬株式会社 貼付剤
JP5097359B2 (ja) 2006-05-09 2012-12-12 久光製薬株式会社 ドネペジル経皮吸収型製剤
US20090239828A1 (en) * 2006-09-11 2009-09-24 Yuuhiro Yamazaki Adhesive preparation
BRPI0718600A2 (pt) 2006-11-09 2013-12-10 Pfizer Prod Inc Polimorfos de intermediários nicotínicos.
WO2008105038A1 (ja) * 2007-02-23 2008-09-04 Nichiban Company Limited 抗真菌症用貼付剤

Also Published As

Publication number Publication date
EP2255809A1 (en) 2010-12-01
EP2258369B1 (en) 2015-04-08
WO2009107476A1 (ja) 2009-09-03
JP6054013B2 (ja) 2016-12-27
JP5485135B2 (ja) 2014-05-07
JPWO2009107477A1 (ja) 2011-06-30
ES2778724T3 (es) 2020-08-11
EP2258369A1 (en) 2010-12-08
JP5537412B2 (ja) 2014-07-02
EP2258355A4 (en) 2011-05-04
EP2258369A4 (en) 2011-05-04
ES2648197T3 (es) 2017-12-29
EP2258355A1 (en) 2010-12-08
EP2255809A4 (en) 2011-05-04
US20110008398A1 (en) 2011-01-13
JPWO2009107476A1 (ja) 2011-06-30
EP2258355B1 (en) 2020-01-22
US20110002976A1 (en) 2011-01-06
US8871249B2 (en) 2014-10-28
EP2255809B1 (en) 2017-08-23
US8580281B2 (en) 2013-11-12
WO2009107477A1 (ja) 2009-09-03
US20110028880A1 (en) 2011-02-03
JPWO2009107479A1 (ja) 2011-06-30
WO2009107479A1 (ja) 2009-09-03

Similar Documents

Publication Publication Date Title
ES2536206T3 (es) Parche medicinal
ES2502472T3 (es) Composición adhesiva para su uso en un inmunosensor
ES2524320T3 (es) Composición para la prevención o el tratamiento de enfermedad asociada con trombo o émbolo
AR117799A2 (es) Sal(es) de dimetil-amida del ácido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]-pirimidin-6-carboxílico y procesos para su elaboración
ES2646737T3 (es) Sistema terapéutico transdérmico para clorhidrato de ácido 5-aminolevulínico
ES2552651T3 (es) Composición inyectable de polidesoxirribonucleótido para el tratamiento de enfermedades osteoarticulares
ES2488407T3 (es) Preparación farmacéutica que contiene lipasa de origen bacteriano
ES2543957T3 (es) Nueva composición farmacéutica para el tratamiento de infecciones fúngicas
CL2009002073A1 (es) Composicion farmaceutica solida para la liberacion controlada de un agente activo activo en el tracto gastrointestinal que comprende al menos un agente acido con solubilidad de menos de 0,3 mg/ml en solucion acuosa a un ph alrededor del pka del agente acido, un polimero hidrofilo, un alcanizador; uso en trastornos cardiovasculares.
CL2011003094A1 (es) Composicion farmaceutica semi-solida libre de agua que comprende a) un ester del acido 5-aminolevulinico (5-ala) o una sal del mismo, b) uno o mas trigliceridos y c) opcionalmente uno o mas potenciadores de viscosidad; kit farmaceutico; y su uso en el tratamiento fotodinamico del cancer, condiciones pre-cancerosas y no cancerosas asociadas a hpv.
PE20141672A1 (es) FORMULACION PARA ANTICUERPO ANTI-alfa4�7
SV2008003106A (es) Composicion farmaceutica estable que contiene docetaxel y un metodo para fabricarla
MX365522B (es) Sistemas de administracion y formulacion de farmacos de retencion gastrica, y metodo para su preparacion usando carbonato de calcio funcionalizado.
MX2016010169A (es) Formulacion de tableta para compuestos activos de peptido relacionado con el gen de calcitonina.
AR079890A1 (es) Estabilizacion de peliculas de oxido de zinc en composiciones bucales
CL2017002111A1 (es) Composición ácida a base de leonardita y aminoácidos
AR090307A1 (es) Polimeros cationicos a base de glucogeno
BR112015031158A2 (pt) síntese de (met)acrilatos de ácido carboxílico alfa,beta-insaturado a partir de olefinas e co2
MX2020005738A (es) Derivados de glutarimida, uso de los mismos, composicion farmaceutica basada en los mismos y metodos para producir derivados de glutarimida.
NZ593524A (en) A nonapeptide with anti-tumour activity
ES2596245T3 (es) Procedimiento para la purificación de acetato de abiraterona
ES2482168T3 (es) Uso de opioides del grupo de la metadona para el tratamiento de pacientes con cáncer resistente
CO2017005201A2 (es) Ácido benzóico, derivados de ácido benzóico y conjugados heteroarilcarboxílico de la oxicodona
CO7240370A2 (es) Forma farmaceútica para la liberación prolongada de sustancias activas
ES2664171T3 (es) Aditivo retardador del fraguado y plastificante para el hormigón